| scholarly article | Q13442814 |
| P2093 | author name string | Primo Schär | |
| Roland Rad | |||
| Giancarlo Marra | |||
| Faiza Noreen | |||
| Luigi Tornillo | |||
| Miguel Silva | |||
| Kaspar Truninger | |||
| Hannah Parker | |||
| Stefan Weis | |||
| Taya Küng | |||
| P2860 | cites work | TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS | Q24312040 |
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| TGF-β - an excellent servant but a bad master | Q27025590 | ||
| A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. | Q27852431 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Wnt signaling and cancer | Q27860871 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer | Q28239338 | ||
| The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype | Q28247866 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation | Q29615366 | ||
| IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype | Q29617457 | ||
| CIMP status of interval colon cancers: another piece to the puzzle | Q33348336 | ||
| Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling | Q33520213 | ||
| Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis | Q33759128 | ||
| Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. | Q33958348 | ||
| Cancer genetics and epigenetics: two sides of the same coin? | Q34287662 | ||
| Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. | Q34300885 | ||
| Association between molecular subtypes of colorectal cancer and patient survival | Q34759064 | ||
| Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history | Q35163670 | ||
| BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum | Q35596687 | ||
| Genome-scale analysis of aberrant DNA methylation in colorectal cancer | Q35694387 | ||
| CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations | Q35807863 | ||
| A DNA hypermethylation module for the stem/progenitor cell signature of cancer. | Q35914847 | ||
| The MAPK signalling pathways and colorectal cancer | Q36111490 | ||
| The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
| Molecular classification and correlates in colorectal cancer | Q36329300 | ||
| Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. | Q36517044 | ||
| Serrated colon polyps as precursors to colorectal cancer | Q36771915 | ||
| HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. | Q36932231 | ||
| Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells | Q37095651 | ||
| Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas | Q37274510 | ||
| Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch | Q38049051 | ||
| The serrated pathway to colorectal carcinoma: current concepts and challenges | Q38075894 | ||
| Microsatellite instability in interval colon cancers | Q38435356 | ||
| Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation | Q38641499 | ||
| A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer | Q38771093 | ||
| The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort | Q38981916 | ||
| Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma | Q39304634 | ||
| Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer | Q40847447 | ||
| Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia. | Q48126035 | ||
| SDH mutations establish a hypermethylator phenotype in paraganglioma. | Q50960567 | ||
| Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. | Q50970640 | ||
| Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. | Q51670556 | ||
| Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. | Q52118607 | ||
| Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. | Q52603962 | ||
| Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile. | Q52625681 | ||
| CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients | Q57186636 | ||
| Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2 | Q58588233 | ||
| The proto CpG island methylator phenotype of sessile serrated adenomas/polyps | Q58606681 | ||
| Methylation pattern of different regions of theMLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer | Q61196002 | ||
| Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer | Q64122042 | ||
| Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis | Q80422796 | ||
| Molecular genetics of colorectal cancer | Q82521439 | ||
| Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer | Q91361266 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| minfi | Q113334816 | ||
| P433 | issue | 1 | |
| P921 | main subject | colon cancer | Q18555025 |
| P304 | page(s) | 196 | |
| P577 | publication date | 2019-12-16 | |
| P1433 | published in | Clinical Epigenetics | Q18620113 |
| P1476 | title | DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways | |
| P478 | volume | 11 |
Search more.